KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) Return on Sales (2016 - 2025)

Historic Return on Sales for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to 0.09%.

  • BeOne Medicines' Return on Sales rose 2100.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 2700.0%. This contributed to the annual value of 0.17% for FY2024, which is 1900.0% up from last year.
  • Per BeOne Medicines' latest filing, its Return on Sales stood at 0.09% for Q3 2025, which was up 2100.0% from 0.07% recorded in Q2 2025.
  • Over the past 5 years, BeOne Medicines' Return on Sales peaked at 0.28% during Q3 2023, and registered a low of 3.2% during Q2 2021.
  • Moreover, its 5-year median value for Return on Sales was 0.58% (2023), whereas its average is 0.84%.
  • As far as peak fluctuations go, BeOne Medicines' Return on Sales surged by 71200bps in 2021, and later crashed by -15300bps in 2022.
  • Quarter analysis of 5 years shows BeOne Medicines' Return on Sales stood at 2.76% in 2021, then soared by 58bps to 1.17% in 2022, then skyrocketed by 51bps to 0.58% in 2023, then soared by 77bps to 0.13% in 2024, then soared by 166bps to 0.09% in 2025.
  • Its Return on Sales stands at 0.09% for Q3 2025, versus 0.07% for Q2 2025 and 0.0% for Q1 2025.